Stability studies indicated ORI@CPD-Lipo stored at 4 C for 21 days exhibited no significant changes in appearance or physicochemical properties, and the solution remained homogeneous and stable
Possible reactions noted in the available literature include injection-site irritation, mild headache or fatigue, transient changes in dream vividness or sleep timing, and, occasionally, mild mood shifts or increased restlessness
All-Cause Mortality and Gastrointestinal Adverse Effects in Adults With Type 2 Diabetes on Glucagon-Like Peptide-1 Receptor Agonists vs Sodium-Glucose Cotransporter-2 Inhibitors
Analyzing your family's medical history helps reveal important information about your personal stress management methods
Abstract Several peptide dual agonists of the human glucagon receptor (GCGR) and the glucagon-like peptide-1 receptor (GLP-1R) are in development for the treatment of type 2 diabetes, obesity and their associated complications
We standardized all IIEF-EF scores to a 6 to 30 scale to ensure consistent results across trials